BIIB
Alprolix® (rFIXFc) Approved in the EU for the Treatment of Haemophilia B
Friday, May 13, 2016 1 min read
Key Takeaway: Alprolix® (rFIXFc) Approved in the EU for the Treatment of Haemophilia B
Full Press Release Details
Alprolix® (rFIXFc) Approved in the EU for the Treatment of Haemophilia B.